Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has a market cap or net worth of HKD 7.82 billion. The enterprise value is 6.52 billion.

Market Cap	7.82B
Enterprise Value	6.52B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Aug 26, 2024

Share Statistics

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has 1.04 billion shares outstanding. The number of shares has increased by 0.98% in one year.

Shares Outstanding	1.04B
Shares Change (YoY)	+0.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.21%
Owned by Institutions (%)	3.72%
Float	410.26M

Valuation Ratios

The trailing PE ratio is 24.58.

PE Ratio	24.58
Forward PE	n/a
PS Ratio	3.70
PB Ratio	1.15
P/FCF Ratio	17.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 51.02, with an EV/FCF ratio of 39.33.

EV / Earnings	54.84
EV / Sales	8.24
EV / EBITDA	51.02
EV / EBIT	87.85
EV / FCF	39.33

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.01.

Current Ratio	3.88
Quick Ratio	3.72
Debt / Equity	0.01
Debt / EBITDA	0.10
Debt / FCF	0.08
Interest Coverage	45.59

Financial Efficiency

Return on equity (ROE) is 4.72% and return on invested capital (ROIC) is 1.80%.

Return on Equity (ROE)	4.72%
Return on Assets (ROA)	1.47%
Return on Capital (ROIC)	1.80%
Revenue Per Employee	866,222
Profits Per Employee	130,238
Employee Count	948
Asset Turnover	0.25
Inventory Turnover	1.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.91% in the last 52 weeks. The beta is 0.29, so Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	+11.91%
50-Day Moving Average	2.01
200-Day Moving Average	2.11
Relative Strength Index (RSI)	56.71
Average Volume (20 Days)	7,510,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. had revenue of HKD 790.86 million and earned 118.91 million in profits. Earnings per share was 0.11.

Revenue	790.86M
Gross Profit	724.46M
Operating Income	74.22M
Pretax Income	114.20M
Net Income	118.91M
EBITDA	118.85M
EBIT	74.22M
Earnings Per Share (EPS)	0.11

Balance Sheet

The company has 1.31 billion in cash and 13.13 million in debt, giving a net cash position of 1.30 billion or 1.25 per share.

Cash & Cash Equivalents	1.31B
Total Debt	13.13M
Net Cash	1.30B
Net Cash Per Share	1.25
Equity (Book Value)	2.53B
Book Value Per Share	2.44
Working Capital	1.49B

Cash Flow

In the last 12 months, operating cash flow was 222.87 million and capital expenditures -57.10 million, giving a free cash flow of 165.77 million.

Operating Cash Flow	222.87M
Capital Expenditures	-57.10M
Free Cash Flow	165.77M
FCF Per Share	0.16

Margins

Gross margin is 91.60%, with operating and profit margins of 9.39% and 15.04%.

Gross Margin	91.60%
Operating Margin	9.39%
Pretax Margin	14.44%
Profit Margin	15.04%
EBITDA Margin	15.03%
EBIT Margin	9.39%
FCF Margin	20.96%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 1.56%.

Dividend Per Share	0.04
Dividend Yield	1.56%
Dividend Growth (YoY)	22.06%
Years of Dividend Growth	n/a
Payout Ratio	68.81%
Buyback Yield	-0.98%
Shareholder Yield	0.58%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has an Altman Z-Score of 9.82.

Altman Z-Score	9.82
Piotroski F-Score	n/a